Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Burning Rock Biotech Q2 EPS $(0.10) Up From $(1.40) YoY, Sales $20.737M Up From $18.650M YoY

Author: Benzinga Newsdesk | September 08, 2025 01:00am
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.10) per share. This is a 92.86 percent increase over losses of $(1.40) per share from the same period last year. The company reported $20.737 million in sales this quarter. This is a 11.19 percent increase over sales of $18.650 million the same period last year.

Posted In: BNR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist